Position in LQDA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,650,099
New position
Shares Held
96,717
first reported quarter
Ownership
0.109%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Empowered Funds, LLC holds $54,609,799 across 18 Drug Manufacturers - Specialty & Generic names. LQDA ranks #6 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
20,784 | $12,324,493 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
83,971 | $11,062,337 | |
| 3 | PCRX |
Pacira BioSciences, Inc.
|
276,776 | $6,255,136 | |
| 4 | PRGO |
PERRIGO Co plc
|
511,872 | $5,497,505 | |
| 5 | ZTS |
Zoetis Inc.
|
42,888 | $5,069,783 | |
| 6 | LQDA |
Liquidia Corp
This page
|
96,717 | $3,650,099 | |
| 7 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
181,332 | $3,552,293 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
57,384 | $1,897,688 |
All Filings in LQDA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,650,099 | 96,717 | Shares | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||